Vir Biotechnology (VIR) Stock Price, Quote, News & History | Benzinga

Vir Biotechnology Inc (VIR) Stock Price, Quote, News & History

VIRNASDAQ

Trade with Public

Trade with Public

$8.25

-0.26-3.06%

At close: Jun 10, 5:00 PM EST

$8.37

0.121.45%

After Hours: 5:55 PM EST

OverviewNews Earnings Events Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$8.46

Close

$8.25

Volume / Avg.

1.71M / 1.90M

Day Range

$8.16 - $8.65

52 Wk Range

4.16 - 11.66

Market Cap

$1.35B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

36

Short Interest

11.51%

Days to Cover

10.81

Recent Vir Biotechnology Inc News

Stock Market Today: S&P 500 Futures Slip As Dow, Nasdaq 100 Gain Following Trump's Tariff Threat — Whirlpool, Uber, HP In Focus (UPDATED)

(Editor’s note: The future prices of benchmark tracking ETFs, the lede, the economic data, and the headline were updated in the story.) U.S. stock futures pared earlier gains and fluctuated on Tuesday after closing lower on Monday. Futures of all the major benchmark indices were mixed following a sell-off.

Rishabh Mishra

Vir Biotechnology Stock Hits 52-Week High Tuesday - Here's Why

Vir Biotechnology stock skyrockets after $335 million Astellas deal, strong prostate cancer data, and upbeat earnings boost outlook.

Vandana Singh

Morgan Stanley Doubles Vir Biotechnology Price Forecast - Here's Why

Vir Biotechnology's Phase 1 data highlights early promise for T-cell engagers targeting HER2-positive tumors and prostate cancer with manageable safety.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-446.05M

Investing Cash Flow (TTM)

195.39M

Financing Cash Flow (TTM)

165.71M

Free Cash Flow (TTM)

-449.64M

Capital Expenditure (TTM)

-3.59M

Net Change in Cash (TTM)

-84.95M

Analyst Trends and Forecast

1

Dec 25

5

Feb

1

Mar

1

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.01B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

17.98

PB Ratio (TTM)

1.71

Earnings Yield % (TTM)

-37.94%

Earnings Yield % (FWD)

-18.79%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$4.82

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$274.16M

Debt to Equity

0.12

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$8.46

Close

$8.25

Volume / Avg.

1.71M / 1.90M

Day Range

$8.16 - $8.65

52 Wk Range

4.16 - 11.66

Market Cap

$1.35B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

36

Short Interest

11.51%

Days to Cover

10.81

About

Sector

Health Care

Industry

Biotechnology

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Vir Biotechnology (VIR) stock?

A

You can purchase shares of Vir Biotechnology (NASDAQ:VIR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Vir Biotechnology (VIR) competitors?

A

There are no as such competitors for Vir Biotechnology.

Q

What is the forecast, or price target, for Vir Biotechnology (VIR) stock?

A

Vir Biotechnology has a consensus price target of $27.75.

Q

What is the current price for Vir Biotechnology (VIR)?

A

The stock price for Vir Biotechnology (NASDAQ: VIR) is $8.37 last updated June 10, 2026 at 5:55 PM EDT.

Q

Does Vir Biotechnology (VIR) pay a dividend?

A

There are no upcoming dividends for Vir Biotechnology.

Q

When is Vir Biotechnology (NASDAQ:VIR) reporting earnings?

A

Vir Biotechnology does not have any upcoming earnings scheduled.

Q

Is Vir Biotechnology (VIR) going to split?

A

There is no upcoming split for Vir Biotechnology.

Q

What sector and industry does Vir Biotechnology (VIR) operate in?

A

Vir Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.